SIGN UP
LOG IN
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga·04/23/2025 12:06:43
Listen to the news
Gainers
- Sonoma Pharmaceuticals (NASDAQ:SNOA) shares increased by 98.3% to $4.62 during Wednesday's pre-market session. The market value of their outstanding shares is at $7.4 million.
- GlycoMimetics (NASDAQ:GLYC) stock moved upwards by 25.91% to $0.29. The market value of their outstanding shares is at $18.3 million.
- ENDRA Life Sciences (NASDAQ:NDRA) stock rose 24.78% to $3.85. The company's market cap stands at $2.0 million.
- Forte Biosciences (NASDAQ:FBRX) shares rose 22.62% to $8.4. The market value of their outstanding shares is at $53.7 million.
- Rezolute (NASDAQ:RZLT) stock rose 21.28% to $3.77. The company's market cap stands at $228.3 million.
- Ensysce Biosciences (NASDAQ:ENSC) shares increased by 17.11% to $2.19. The company's market cap stands at $3.0 million.
Losers
- Serina Therapeutics (AMEX:SER) stock fell 21.6% to $4.31 during Wednesday's pre-market session. The company's market cap stands at $42.8 million.
- Gelteq (NASDAQ:GELS) stock declined by 17.37% to $2.38. The market value of their outstanding shares is at $22.4 million.
- NeOnc Technologies (NASDAQ:NTHI) shares decreased by 16.39% to $5.0. The market value of their outstanding shares is at $112.8 million.
- Karyopharm Therapeutics (NASDAQ:KPTI) stock fell 15.26% to $5.11. The company's market cap stands at $43.7 million.
- Intensity Therapeutics (NASDAQ:INTS) stock decreased by 13.62% to $1.65. The market value of their outstanding shares is at $25.0 million.
- Petros Pharma (NASDAQ:PTPI) shares declined by 12.46% to $0.05. The market value of their outstanding shares is at $1.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.